Promoting Personalized Medicine through Policy Strategies
Towards Biomarker—based Personalized Healthcare: Current Status and Future Trends
Integrating Companion Diagnostics in the Healthcare
Regulatory Strategies to Safely Accelerate the Implementation of Companion Diagnostics
The Impact of Genetics and Genomics in Personalized Medicine Development and Innovation
The Future of Academic Research towards Translation for Personalized Medicine
The Gut Microbiome: Insights for Personalized Medicine
The Functional Status of Signal Transduction Pathways to Inform Companion Diagnostics and Personalized Cancer Drug Development
Stratified Medicine in Autoimmune Diseases: Rheumatoid Arthritis Examples
Biomarkers for Precision Medicine in Airway Diseases
The Genetics of Multiple Sclerosis
Cardiovascular Disease
The Impact of Epigenetics on the Future of Personalized Medicine
Therapeutic Target Areas beyond Cancer
Ways to Making Personalized Medicine more Affordable
Approaches to Companion Diagnostics Development
Who should Attend
Healthcare policy makers
International scientists and clinicians from academia, industry, and government
Insurance sector representatives
Regulatory experts
Past Events
Companion Diagnostics: From Biomarker Identification to Market Entry 2014 - 28-29 Apr 2014, New York Academy of Sciences Conference Center, New York City, New York, United States (43145)
Companion Diagnostics: From Biomarker Identification to Market Entry 2026
Important
Please, check "Companion Diagnostics: From Biomarker Identification to Market Entry" official website for possible changes, before making any traveling arrangements
Event Categories
Health & Medicine: AIDS & HIV, Cardiology, Diabetes, Endocrinology, Genetics, Healthcare, Immunology, Infectious diseases, Medical device, Medical laboratories, Medical technology, Metabolism, Neurology, Oncology, Pathology, Pharma, Rheumatology
